HRA003481
Title:
Next Generation Sequencing of BEAS-2B cell line treated with LPS
Release date:
2022-11-26
Description:
The aim of this study was to profile differentially expressed genes in a vitro lipopolysaccharide (LPS) exposure model of asthma in BEAS-2B cell line. BEAS-2B cells were treated with LPS at concentration of 5 mcg/mL, and PBS was used in the control group for 24 h. Then, total RNAs were extracted for high-throughput sequencing and further analysis.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cell line related study
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Science and Technology Committee
Contact person:
Wang JZ
Email:
841179770@qq.com
Description:
The Science and Technology Committee of Yancheng No.1 Hospital is in charge of data release and ethics approval.
Individuals & samples
Submitter:   Wang JINGZHI / 841179770@qq.com
Organization:   The First People's Hospital of Yancheng
Submission date:   2022-11-20
Requests:   -